ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Alzheimers Dis Parkinsonism,
  • DOI: 10.4172/2161-0460.1000520

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimers disease

Walter J. Lukiw1,2,3*
1LSU Neuroscience Center, Louisiana State University Health Science Center, New Orleans LA 70112, AZ USA
2Department of Neurology, LSU Neuroscience Center Louisiana State University Health Science Center, New Orleans LA 70112, AZ USA
3Department of Ophthalmology, LSU Neuroscience Center Louisiana State University Health Science Center, New Orleans LA 70112, AZ USA
*Corresponding Author : Walter J. Lukiw, Bollinger Professor of Alzheimer’s disease, LSU Neuroscience Center, Louisiana State University Health Sciences Center, 2020 Gravier Street, Suite 904, LA 70112, AZ USA, Tel: 5045990842, Email: wlukiw@lsuhsc.edu

Received Date: Apr 19, 2021 / Accepted Date: May 03, 2021 / Published Date: May 10, 2021

Keywords: SARS-CoV-2; ACE2 receptor; Alzheimer’s disease

Citation: Lukiw WJ (2021) SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 11: 520. Doi: 10.4172/2161-0460.1000520

Copyright: © 2021 Lukiw WJ. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top